Editorial
Open access
Oct 2026
Antivascular endothelial growth factor (anti-VEGF) intravitreal (IVT) therapy injections are routinely used to treat retinal diseases, including diabetic macular edema (DME), proliferative diabetic retinopathy (PDR), and neovascular age-related macular degeneration (AMD [nAMD]). Despite their robust efficacy, IVTs may...
Jill Adelman, Randall Barker, B. Best et al.
· Ophthalmology and Therapy · 0 citations